Latest Zecotek Photonics (ZMSPF) Headlines Zecotek files

New Post Public Reply Private Reply Replies (0) Message Board

Mar 12, 2014 at 6:14 AM

Latest Zecotek Photonics (ZMSPF) Headlines

Zecotek files Two US Patents for 3D Display Technology
CNW Group - Thu Mar 06, 8:30AM CST
Zecotek Photonics Inc. (TSX-V: ZMS; Frankfurt: W1I.F), a developer of leading-edge photonics technologies for medical, industrial and scientific markets, today announced that it has filed two important patents with the US Patent Office relating to front and rear-projection autostereoscopic 3D display systems. The first patent application is for a front-projection auto-stereoscopic 3D display system which enables viewers to experience autostereoscopic 3D content through a front-projection system without the need for any special glasses. The second patent application is a rear-projection auto-stereoscopic 3D display system which enables viewers to experience auto-stereoscopic 3D content through a rear-projection system without the need for any special glasses.

Zecotek to Develop 3D Printer
PR Newswire - Thu Feb 27, 8:30AM CST
Zecotek Photonics Inc. (TSX-V: ZMS; Frankfurt: W1I.F), a developer of leading-edge photonics technologies for medical, industrial and scientific markets, today announced thatits wholly owned subsidiary Zecotek Display Systems Pte. Ltd. is designing a unique 3D printer which will offer technical and commercial competitive advantages to existing 3D printers. Zecotek is working with LT-Pyrkal of Yerevan, Armenia, a long time contract partner which developed a number of key elements for Zecotek`s own patented 3D display technology. This is Zecotek`s second product offering to the 3D market following the recently announced 3D printing platform which offers significant design, cost, and time advantages when Zecotek's glasses free, auto-stereoscopic, multi-view, HD 3D display.

Zecotek Receives United States Patent Allowance for its MAPD Solid-State Photo Detector
CNW Group - Wed Feb 19, 7:45AM CST
Zecotek Photonics Inc. (TSX-V: ZMS) (Frankfurt: W1I), a developer of leading-edge photonics technologies for medical, industrial and scientific markets, today announced that the United States Patent Office has issued a Notice of Allowance for its Micro-channel Avalanche Photodiode (MAPD) solid-state photo detector. The Company is focused on strengthening its patent portfolio specific to imaging technology and associated components, and this patent allowance represents another important step is securing intellectual property related to all key elements for a high performance PET scanner.

Zecotek Named to the TSX Venture Top 50 List of Companies
PR Newswire - Thu Feb 13, 1:54PM CST
Zecotek Photonics Inc. (TSX-V: ZMS; Frankfurt: W1I.F), a developer of leading-edge photonics technologies for medical, industrial and scientific markets, has been named a 2014 TSX Venture 50® company by the TMX Group. The TSX Venture 50® ranks the top 10 companies in 5 major industry sectors by identifying those emerging companies which have shown strong results in key measures of market performance. Zecotek was ranked sixth in the list of top Canadian Technology & Life Sciences companies.

Zecotek Engages Waterfront Capital Corporation
Newsfile Corp - Tue Feb 11, 7:18PM CST
full story)

Zecotek Announces 3D Printing Interface for Commercial Applications
CNW Group - Fri Jan 31, 2:15AM CST
Zecotek Photonics Inc. (TSX-V: ZMS; OTCPK: ZMSPF; Frankfurt: W1I), a developer of leading-edge photonics technologies for medical, industrial and scientific markets, today announced that its wholly owned subsidiary Zecotek Display Systems Pte. Ltd. is designing a unique 3D printing interface platform between existing and future generations of 3D printers and its own patented 3D display technology. The 3D printing platform offers significant design, cost, and time advantages when Zecotek's glasses free, auto-stereoscopic, multi-view, HD 3D display is used with commercial 3D printers for the creation of solid objects used in rapid and manufacturing prototyping.

Zecotek Announces Incentive Stock Options
CNW Group - Fri Jan 17, 10:27PM CST
Zecotek Photonics Inc. (TSXV: ZMS) (OTCPK: ZMSPF) (Frankfurt: W1I), a developer of leading-edge photonics technologies for medical, industrial and scientific markets, today announced that it has granted 2,700,000 incentive stock options to directors, employees and consultants for their contributions to the Company. The exercise price of the options is set at $0.82 and will expire in five years. The stock options are subject to regulatory approval.

Zecotek to Attend the 2014 Cantech Investment Conference in Toronto, Canada
CNW Group - Mon Jan 13, 11:01AM CST
Zecotek Photonics Inc. (TSXV: ZMS) (OTCPINK: ZMSPF) (Frankfurt: W1I), a developer of leading-edge photonics technologies for medical, industrial and scientific markets, today announced that the Company will be attending the 2014 Cantech Investment Conference on January 16, 2014 in Toronto, Ontario. Dr. A. Faouzi Zerrouk, Chairman, President, and CEO of Zecotek will be presenting at the conference at 11:25am EST. The Company will also have a booth in the investor's exhibit hall.

Renewed Interest in Glasses Free 3D Presents Opportunity for Zecotek`s Patented 3D Display Technology
PR Newswire - Mon Dec 16, 7:00AM CST
Zecotek Photonics Inc. (TSX-V: ZMS; OTCPK: ZMSPF; Frankfurt: W1I), a developer of leading-edge photonics technologies for medical, industrial and scientific markets, today announced thatits wholly owned subsidiary Zecotek Display Systems Pte. Ltd. is demonstrating patented 3D display technology to major electronics companies in its lab in Vancouver, BC. The Company is in discussions with certain major electronics companies to co-develop an OLED/LED (organic light emitting diode) based, flat screen, glasses-free, true 3D HD television. This progress in the Zecotek Display Systems division, follows the recently signed collaborative joint venture agreement between Hamamatsu Photonics of Japan and Zecotek Imaging Systems to market and sell patented imaging technologies.

BTV-Business Television -- Zecotek Receives $1.5 Million Order for Its Crystals
Newsfile Corp - Fri Nov 29, 5:03AM CST
full story)

Zecotek Receives US$1.5 Million Order for its Patented LFS Scintillation Crystals Through Hamamatsu Photonics Partnership
PR Newswire - Tue Nov 19, 7:45AM CST
Zecotek Photonics Inc. (TSXV: ZMS) (OTCPK: ZMSPF) (Frankfurt: W1I), a developer of leading-edge photonics technologies for medical, industrial and scientific markets, today announced that its wholly owned subsidiary Zecotek Imaging Systems Pte. Ltd. has received a US$1,500,000 order for its patented Lutetium Fine Silicate (LFS) scintillation crystals from its strategic partner Hamamatsu Photonics (Tokyo: 6965) of Japan. This second order of LFS scintillation crystals is generated to be used by a third party OEM of positron emission tomography (PET) medical scanning devices.

/C O R R E C T I O N from Source -- Zecotek Photonics Inc./
PR Newswire - Sun Oct 27, 9:01PM CDT
In TO878 transmitted on Friday, October 25, 2013, an error occurred in the first paragraph. "MAPD photo detectors" should have read "MPPC photo detectors". Corrected copy follows:

Zecotek Photonics (ZMSPF) Stock Research Links

ZMSPF Board Company Profile Buy Rating Time & Sales News Filings Financials

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Monster Energy Unleashes Gaming Frenzy at Cosm L.A. Event

Where Energy Drinks and Digital Reality Collide Monster Energy sure knows how to throw a party, especially when it hinges on something as electrifying as Call of Duty: Modern Warfare 4. Imagine this: Cosm Los Angeles is decked out with a massive 87-foot LED dome, and every gamer, celeb, and influencer ready to dive right in. You can't make this stuff up. They've mashed...

Sinclair Faces Labor Lawsuit for Break-time Violations

Sinclair Television Caught in Labor Law Storm When you think of flaring tempers and boardroom brawls, you typically don't think of your everyday TV station. But right now, Sinclair Television of California, LLC is in the hot seat, accused of playing fast and loose with wage packets—specifically, allegedly denying meal periods and rest breaks that California labor laws...

Miranda Lambert Lights Up Red Kettle Campaign

By Logan Wright Updated Oct 25, 2026 Category News Views 112

A Star-Studded Start to the Season of Giving Miranda Lambert is set to dazzle audiences yet again, and if there's one thing this country music titan knows, it's how to crank up the heartstrings while fanning the flames of generosity. She'll take to the stage at AT&T Stadium this Thanksgiving during the Dallas Cowboys game, bringing a powerful performance to light up the...

Spooky Dining at CARNE: A Halloween Hit in Oxnard

A Festive Transformation at CARNE Rolling into Oxnard, you're met with an unconventional dining spectacle at CARNE. It's not your average restaurant fare as they've pulled out the stops with their spirited Halloween pop-up, A Nightmare at CARNE. Channeling the eerie charm of "The Nightmare Before Christmas," this temporary transformation morphs the venue into a lively,...

Sac-TMT's Phase III Success Shifts Lung Cancer Paradigm

A New Era in Lung Cancer Treatment? Sac-TMT, the novel antibody-drug conjugate (ADC), just might be shaking up the non-small cell lung cancer (NSCLC) treatment landscape, and boy, is it making waves. Just when you think you’ve seen it all, here comes sacituzumab tirumotecan (sac-TMT), offering a glimmer of hope for patients whose treatment options have dwindled after...

Tennessee's Bold Lung Cancer Trial Signals Innovation

The Heartbeat of Innovation in Cancer Therapy Who would've thought Tennessee would be at the forefront of a global push against lung cancer? Sure, there's Nashville's music scene, but it's the researchers at Tennessee Oncology who are grooving to a different beat—one that might just set the rhythm for advanced cancer therapies worldwide. Yeah, it's a trial, but not just...

Innovent's IBI354: New Data Spurs Hope for HER2+ BC

Innovent Lauds HER2 ADC's Moment at ESMO 2026 Alright, chin up, investors. At the 2026 ESMO Congress, Innovent's throwing down some promising Phase 2 data for their brainchild, IBI354. You hear that name and it's like hearing about a rock star in the making in the oncology world. The potential here isn’t just talk—it's a loud, resounding call for attention. Their...

Community in Shock After Fatal Bakersfield Shooting

The Ripple Effect of Tragedy Grief has a way of shaking a community down to its core—especially when the loss emanates from such senseless violence as the shooting death of 17-year-old Levi Brown. This wasn't just a tragic occurrence at a Friday night football game in Bakersfield; it was a visceral crack in the perceived safety of community events. Levi's Legacy and...

Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

LexisNexis Debuts AI-Guided Field Clarity at IACP 2026

LexisNexis Takes a Serious Step Forward The world of law enforcement reporting just got a shake-up. LexisNexis Coplogic Solutions launched a souped-up version of its Desk Officer Reporting System (DORS) at the IACP 2026 event. They paired DORS with Field Clarity, a newfangled AI-powered assistant that aims to make police reporting slicker and more accurate. You can bet...